pembrolizumab
merck
['lcsm,(-blcsm)', 'lung', 'pembro']
for pts who are lucky enough to complete 2-yr of pembro, 3 yr from stopping treatment, 70% chance of being alive &amp; ~45% chance of not needing any other treatment for lung cancer! not something i thought i ll be able to tell my pts when i started my career! #lcsm #esmo22 
VP, Clinical Research @Gileadsciences thoracic oncologist, clinical researcher, a proud Dad. Personal account and opinions, tweets and RT are my own opinion.